Peanut allergy remains one of the most concerning food allergies in pediatrics due to its rising prevalence (affecting approximately 2% of children), its persistence into adulthood, and the risk of severe reactions. However, the scientific evidence accumulated over the past decade has profoundly transformed primary prevention strategies. Current approaches now rely on a key concept : early introduction of peanut into an infant’s diet can significantly reduce the risk of developing an allergy.
A paradigm shift in pediatric allergology
For many years, recommendations aimed to delay the introduction of highly allergenic foods, including peanuts, sometimes until the age of 3. This approach has proven ineffective, and even counterproductive. Large randomized clinical trials, notably the LEAP (Learning Early About Peanut Allergy) study, demonstrated that prolonged avoidance did not prevent allergy and could even increase the risk in some children.
The LEAP study revealed remarkable results : among high-risk infants (severe eczema and/or egg allergy) who regularly consumed peanut from 4 to 11 months of age, only 1.9% developed peanut allergy by age 5, compared to 13.7% in the avoidance group representing an 86% relative risk reduction. These findings led to major changes in international guidelines in allergology and pediatrics.
Early introduction : when and why ?
Current data indicate that introducing peanut between 4 and 6 months, when the infant is developmentally ready (head control, interest in food, ability to swallow), is associated with a marked reduction in peanut allergy risk. Modeling analyses have shown that a 77% reduction in peanut allergy could be achieved if peanut were introduced to all infants at 4 months (in the presence of eczema) or at 6 months (without eczema). This effectiveness decreases with each month of delay : if introduction is postponed until 12 months, the reduction drops to only 33%.
Early exposure is thought to promote the development of immune tolerance, a process by which the immune system learns to recognize a food protein as harmless.
Which infants ?
Current recommendations, including those from the National Institute of Allergy and Infectious Diseases (NIAID) and the American Academy of Pediatrics (AAP), generally distinguish three groups :
High-risk infants (severe eczema and/or known food allergy) : prior medical evaluation is recommended before introduction, including measurement of peanut-specific IgE and/or skin prick testing. If results are negative or weakly positive, introduction can occur as early as 4 to 6 months, sometimes under medical supervision depending on the results.
Moderate-risk infants (mild to moderate eczema) : early introduction is encouraged around 6 months, generally at home, without the need for prior testing.
Infants without specific risk factors : peanut can be introduced freely from 6 months onward, in a safe form, according to family and cultural preferences.
How to introduce peanut safely ?
It is essential to remember that whole peanuts or peanut pieces should never be given to infants due to the risk of choking. Recommended forms include :
- Peanut butter diluted in warm water, breast milk, or puree
- Peanut powder mixed into smooth foods
- Commercial products adapted to the infant’s age
Une petite quantité suffit au départ, avec une observation attentive lors des premières expositions. Il est recommandé de poursuivre la consommation régulière (au moins 3 fois par semaine) pour maintenir la tolérance.
A demonstrated long-term impact
Follow-up studies show that children exposed early to peanut often maintain this tolerance over the long term, even after periods without regular consumption. Individual data analyses have confirmed a 75% reduction in peanut allergy in intention-to-treat analyses, with a protective effect observed across all risk groups, including children without eczema. These results reinforce the relevance of this strategy as a public health measure.
Key message for parents and professionals
Prevention of peanut allergy no longer relies on avoidance, but on early, safe, and gradual introduction as part of normal infant dietary diversification. This approach, supported by robust data from clinical trials and meta-analyses, represents one of the most significant advances in pediatric allergology in recent years.
Conclusion
Introducing peanut early in infants’ diets is now an effective, evidence-based strategy to reduce the risk of allergy. Effectiveness is greatest when introduction occurs between 4 and 6 months, followed by regular consumption. As always, recommendations should be tailored to each child, and parents are encouraged to discuss dietary diversification with a healthcare professional, particularly for high-risk infants who require prior evaluation.


